 |
Glyceryl tri (4-phenylbutyrate) |
|---|---|
| Trade Name | |
| Orphan Indication | Spinal muscular atrophy |
| USA Market Approval | USA |
| USA Designation Date | 2005-05-24 00:00:00 |
| Sponsor | Ucyclyd Pharma, Inc;Subsidiary of Medicis Pharmaceutical Corporation, 7720 N. Dobson Road;Scottsdale, Arizona, 85256 |
Related Access Program
Pfizer – Non Small Cell Lung Cancer With ALK or ROS1 Rearrangement
Pfizer – Non Small Cell Lung Cancer Harboring Molecular Alterations
Biogen – Infantile-onset Spinal Muscular Atrophy
Novartis Pharmaceuticals – Non-small Cell Lung Cancer (NSCLC)
Biogen – Infantile-onset Spinal Muscular Atrophy (SMA)